HOUSTON — With Gerrit Cole and Carlos Rodón’s rehab assignments underway, the Yankees’ rotation could experience some overcrowding in the near future. Their returns are not imminent, as Rodón, ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Carlos Mendoza explains the reason behind the New York Mets are using a five-man rotation despite having six starting pitchers available. Starting pitching was a major issue for the New York Mets last ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...

Spring training performances will certainly have something to do with this decision, but there's a real world where the New York Yankees roll out just four starters through the first two weeks. New ...

A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...

WASHINGTON, March 2 (Reuters) - Three U.S. cabinet agencies on Monday moved to cease use of Anthropic's AI products, joining the military in directing staff to use models from rivals such ‌as OpenAI ...

Washington — President Trump announced Friday that he is ordering all federal agencies to "immediately" stop using Anthropic's artificial intelligence technology, as the company neared a Pentagon ...

Make that seven losses in a row for the Chicago Bulls. To this group's credit, they avoided the kind of blowout loss Toronto handed them back on February 5. The effort level was high, but the ...

The nation’s largest purveyor of licensing exams for teachers now offers a gauge of whether teachers have the skills to use artificial intelligence—the latest sign that the technology continues to ...

A Roche obesity drug designed to hit two targets led to weight loss that is competitive with other drugs in its class, but from a development standpoint, the drug candidate still trails rival ...